why is cvna stock dropping?
604109
Shares of Carvana (NYSE:CVNA) were pulling back today after the online used-car dealer announced a secondary offering, its second equity offering in less than two months, as the company seeks to improve its cash position during a volatile period. As of 11:37 a.m. EDT on Tuesday, the stock was down 8.8%.
11108
What happened. Shares of Novavax (NASDAQ:NVAX) were down by 10.4% on Wednesday, even though the vaccine maker did not report any news, and the stock market was up today. ... And so investors are less confident that Novavax will make a fortune off its potential COVID-19 vaccine.
1013783
In August, Cisco (ticker: CSCO) said it was seeing a negative impact from the trade war, with the company unable to close some of its deals. Its shares fell 9% because of mixed commentary, a day after it reported financial results for the quarter ended in July. Cisco stock has underperformed the general stock market.
1052565
Apr 13, 2020 (Market Realist via COMTEX) -- Nvidia (NASDAQ:NVDA) stock fell over 1% in today's trading session at 9:50 AM ET. ... Also, the S&P 500 and the Nasdaq Composite lost about 1.4% and 0.8%, respectively. The broader indexes fell due to uncertainty amid COVID-19.
1207028
According to present data Abattis Bioceuticals's ATTBF shares and potentially its market environment have been in bearish cycle last 12 months (if exists). ... Our Ai stock analyst implies that there will be a negative trend in the future and the ATTBF shares are not a good investment for making money.
1317228
WEED, Inc (BUDZ) Stock Market info Currently there seems to be a trend where stocks in the Healthcare sector(s) are not very popular in this period. Our Ai stock analyst implies that there will be a negative trend in the future and the BUDZ shares are not a good investment for making money.
141050
[+] (Photo via Smith Collection/Gado/Getty Images). Nvidia stock (NASDAQ: NVDA) had seen a significant drop this year – dropping by about 17%, from $236 at the end of 2019 to close to $196 on 16th March 2020, as growing fears around the coronavirus outbreak triggered a sell-off across global equity markets.
85987
The Kwality stock fell in trade on Wednesday after the firm deferred a decision on buyback of securities, bonus issue of securities and payment of interim dividend in a board meeting. The stock of dairy products manufacturer was trading 4.84% lower at 20.65 level, a five-year low on BSE.
349188
The rating shows CVS stock is a market laggard in terms of price performance. The Rating runs from 1 (worst) to 99 (best). A 99 rating means the stock is outperforming 99% of all stocks in terms of relative share price performance over the last 52 weeks.
561061
Our Ai stock analyst implies that there will be a negative trend in the future and the TRNX shares are not a good investment for making money. Since this share has a negative outlook we recommend looking for other projects instead to build a portfolio.
924039
['CV Sciences (OTCMKTS: CVSI) ... ', 'Charlottes Web (CSE: CWEB) ... ', 'Cronos Group (NASDAQ:CRON)']
926787
It doesn't look great currently, it has given a very strong selling signal recently, it should be sold as it will only move up in case of positive news else it will keep making fresh lows. Remain away from RCom.
359607
(NYSE:GNC) for five years would be nursing their metaphorical wounds since the share price dropped 98% in that time. And it's not just long term holders hurting, because the stock is down 58% in the last year. ... During five years of share price growth, GNC Holdings moved from a loss to profitability.
748778
Specifically, DexCom's stock was down by an eye-catching 13.8% as of 10:37 a.m. EDT Monday morning. DexCom, along with most other U.S. stocks, is reacting negatively to both the Federal Reserve's emergency rate cut over the weekend and the fallout resulting from the continued spread of COVID-19 across the globe.
329005
The broader indexes fell due to uncertainty amid COVID-19. On April 10, Nvidia stock fell 1.5% and closed at $262.95 with a market cap of $160.9 billion. The stock price has risen 2.9% in the trailing five-day period, while it has risen 38.9% in the trailing 12-month period.
221259
Teva stock has experienced a massive decline over the past few years, and ongoing debt issues continue to weigh the company down. It also faced an onslaught of legal actions ranging from opioid scandals to a recent whistleblower lawsuit, and at the time of this writing, the litigation debacle rages on.
1141859
The stock started downward movement with the monthly close of 4181 on Nov18. It has become the breakout close as the important band of monthly closes 4297-4240 got broken and stock price started making new lows month by month.